WO2006090265A3 - Procedes de preparation de levetiracetam, son intermediaire et utilisation de levetiracetam dans des compositions pharmaceutiques - Google Patents
Procedes de preparation de levetiracetam, son intermediaire et utilisation de levetiracetam dans des compositions pharmaceutiques Download PDFInfo
- Publication number
- WO2006090265A3 WO2006090265A3 PCT/IB2006/000424 IB2006000424W WO2006090265A3 WO 2006090265 A3 WO2006090265 A3 WO 2006090265A3 IB 2006000424 W IB2006000424 W IB 2006000424W WO 2006090265 A3 WO2006090265 A3 WO 2006090265A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- levetiracetam
- preparation
- processes
- pharmaceutical compositions
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des procédés permettant de préparer (S)-2-aminobutanamide de la formule I ainsi que l'utilisation du composé de la formule I comme intermédiaire pour la préparation de lévétiracétam de formule II. L'invention concerne également un procédé de préparation de lévétiracétam et des compositions pharmaceutiques comportant le lévétiracétam.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN435/DEL/2005 | 2005-02-28 | ||
IN435DE2005 | 2005-02-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006090265A2 WO2006090265A2 (fr) | 2006-08-31 |
WO2006090265A3 true WO2006090265A3 (fr) | 2006-10-19 |
Family
ID=36385096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/000424 WO2006090265A2 (fr) | 2005-02-28 | 2006-02-28 | Procedes de preparation de levetiracetam, son intermediaire et utilisation de levetiracetam dans des compositions pharmaceutiques |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006090265A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008077035A2 (fr) * | 2006-12-18 | 2008-06-26 | Dr. Reddy's Laboratories Ltd. | Procédés de préparation de lévétiracétam |
CN102558012B (zh) * | 2012-03-15 | 2013-12-25 | 台州市知青化工有限公司 | 一种左乙拉西坦的合成方法 |
CN102898324A (zh) * | 2012-10-19 | 2013-01-30 | 阜新龙瑞化工有限责任公司 | 一种(s)-2-氨基丁酰胺盐酸盐的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4696943A (en) * | 1984-05-15 | 1987-09-29 | U C B Societe Anonyme | (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
WO2004069796A2 (fr) * | 2003-02-03 | 2004-08-19 | Teva Pharmaceutical Industries Ltd. | Procede de production de levetiracetam |
EP1566376A1 (fr) * | 2004-02-18 | 2005-08-24 | Dr. Reddy's Laboratories Limited | Préparation d'amides d'aminoacides |
-
2006
- 2006-02-28 WO PCT/IB2006/000424 patent/WO2006090265A2/fr not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4696943A (en) * | 1984-05-15 | 1987-09-29 | U C B Societe Anonyme | (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
WO2004069796A2 (fr) * | 2003-02-03 | 2004-08-19 | Teva Pharmaceutical Industries Ltd. | Procede de production de levetiracetam |
EP1566376A1 (fr) * | 2004-02-18 | 2005-08-24 | Dr. Reddy's Laboratories Limited | Préparation d'amides d'aminoacides |
Non-Patent Citations (2)
Title |
---|
KENDA, BENOIT M. ET AL: "Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity", JOURNAL OF MEDICINAL CHEMISTRY , 47(3), 530-549 CODEN: JMCMAR; ISSN: 0022-2623, 2004, XP002383261 * |
KOENIGS ERNST, MYLO BRUNO: "über einige Amide von Aminosäuren", CHEMISCHE BERICHTE, vol. 41, 1908, pages 4427 - 4443, XP009067193 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006090265A2 (fr) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006114520A3 (fr) | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation | |
WO2008127364A3 (fr) | Composés antiviraux et utilisation de ceux-ci | |
WO2007052023A3 (fr) | Composes | |
WO2008062376A3 (fr) | Procédé de fabrication de dérivés de 2-imino-thiazolidino-4-one | |
TW200745003A (en) | Novel compounds | |
WO2007065595A3 (fr) | Derives de la xanthine, procedes de preparation et utilisations de ceux-ci | |
TW200630336A (en) | Novel compounds | |
WO2007146965A3 (fr) | Composés destinés au traitement d'une maladie périodontale | |
TW200621690A (en) | Novel compounds | |
WO2007030361A3 (fr) | Composes de benzimidazole thiophene | |
WO2007109279A3 (fr) | Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation | |
WO2005086656A3 (fr) | Derives d'heteroarylaminopyrazole utilises pour traiter le diabete | |
WO2008001195A3 (fr) | Nouveaux procédés de synthèse d'inhibiteurs de dpp iv | |
WO2010049454A3 (fr) | Composition antimicrobienne tirée de copépodes | |
WO2008017346A3 (fr) | Utilisation de dérivés d'acide ascorbique pour la fonctionnalisation de matrices | |
WO2007130822A3 (fr) | Modulateurs des récepteurs mglur5 iii | |
WO2008149345A3 (fr) | Composés triarylés et compositions les comprenant | |
TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
WO2006056695A8 (fr) | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation | |
WO2008021346A3 (fr) | Palipéridone pure et ses procédés d'obtention | |
WO2008073863A3 (fr) | Préparation et utilité d'allylamines substituées | |
WO2007087026A3 (fr) | Forme solide de amg 706 et compositions pharmaceutiques contenant ledit composé | |
WO2005112923A3 (fr) | Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete | |
NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme | |
WO2008033935A3 (fr) | Dérivés de la vinorelbine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06710471 Country of ref document: EP Kind code of ref document: A2 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6710471 Country of ref document: EP |